Stenocare A/S (CPH:STENO)
Denmark · Delayed Price · Currency is DKK 1.215
-0.070 (-5.45%)
May 8, 2026, 4:51 PM CET
Stenocare Market Cap
Stenocare has a market cap or net worth of 52.48 million as of May 8, 2026. Its market cap has increased by 696.00% in one year.
Market Cap
52.48M
Enterprise Value
53.35M
Revenue
9.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.22
Market Cap Chart
Since May 18, 2020, Stenocare's market cap has decreased from 326.86M to 52.48M, a decrease of -83.94%. That is a compound annual growth rate of -26.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 55.51M | -13.18% |
| Dec 30, 2025 | 63.93M | 146.13% |
| Dec 30, 2024 | 25.97M | -43.63% |
| Dec 29, 2023 | 46.08M | -56.10% |
| Dec 30, 2022 | 104.96M | -11.04% |
| Dec 30, 2021 | 117.98M | -47.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| May 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.27T |
| Genmab | 106.57B |
| Coloplast | 91.08B |
| ALK-Abelló | 56.81B |
| ChemoMetec | 5.31B |
| BioPorto | 579.28M |
| ViroGates | 95.60M |
| Pharma Equity Group | 95.50M |